tiprankstipranks
Trending News
More News >
X4 Pharmaceuticals Inc (XFOR)
NASDAQ:XFOR
US Market

X4 Pharmaceuticals (XFOR) Income Statement

Compare
1,111 Followers

X4 Pharmaceuticals Income Statement

Last quarter (Q3 2025), X4 Pharmaceuticals's total revenue was $1.76M, an increase of 215.18% from the same quarter last year. In Q3, X4 Pharmaceuticals's net income was $-29.82M. See X4 Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.56M$ 0.00$ 0.00$ 0.00$ 3.00M
Gross Profit
$ 1.76M$ 0.00$ 0.00$ -1.89M$ 3.00M
Operating Expenses
$ 38.16M$ 107.52M$ 87.57M$ 85.11M$ 62.87M
Depreciation and Amortization
$ 796.00K$ 419.00K$ 513.00K$ 499.00K$ 1.23M
EBITDA
$ -27.58M$ -94.89M$ -89.33M$ -84.54M$ -58.06M
Operating Income
$ -36.40M$ -107.52M$ -87.57M$ -85.11M$ -59.87M
Other Income/Expenses
$ -739.00K$ 6.43M$ -6.27M$ -3.57M$ -2.11M
Pretax Income
$ -37.14M$ -101.09M$ -93.84M$ -88.68M$ -61.98M
Net Income
$ -37.45M$ -101.17M$ -93.87M$ -88.70M$ -62.13M
Per Share Metrics
Basic EPS
$ -5.59$ -17.10$ -45.60$ -119.70$ -92.70
Diluted EPS
$ -5.59$ -17.10$ -45.60$ -119.70$ -92.70
Weighted Average Shares Outstanding
6.70M----
Weighted Average Shares Outstanding (Diluted)
6.70M----
Currency in USD

X4 Pharmaceuticals Earnings and Revenue History